| Visit |  |  |  |  |
---|---|---|---|---|---|
Information | Enrolment | Allocation, visit 0 | Post-allocation, visits 1–7 | Close-out | |
Timepoint | Day 0 | Day 0 | Day 0 | Days 1–7 | Day 30 |
Location | Hospital | Hospital | Hospital | Hospital | Hospital |
Next of kin information | X* | X* | X | Â | Â |
Signed informed consent | Â | X* | Â | Â | Â |
Plasma βHCG assay |  | X(*) |  |  |  |
Eligibility criteria check | X* | X* | X* | Â | Â |
Randomization | Â | Â | X* | Â | Â |
Study drug administration | Â | Â | X*d | X*d | Â |
Clinical examinationa | Â | X | X | X | Â |
Diagnostic testsb | Â | X | X | X | Â |
Blood assayc | Â | Â | X* | X* | Â |
Adverse effect recording | Â | X* | X* | X* | X* |
Concomitant medications | Â | X | X | X | X |